Topics
News
CME/CE
Editorial Advisory Board
Partners
Subscribe
- General Dermatology
- Eczema
- Alopecia
- Aesthetics
- Vitiligo
- COVID-19
- Actinic Keratosis
- Precision Medicine and Biologics
- Rare Disease
- Wound Care
- Rosacea
- Psoriasis
- Psoriatic Arthritis
- Atopic Dermatitis
- Melasma
- NP and PA
- Skin Cancer
- Hidradenitis Suppurativa
- Drug Watch
- Pigmentary Disorders
- Acne
- Pediatric Dermatology
- Practice Management
Syndrome X - identification and treatment
Washington D.C. - Stephen E. Chiarello, M.D., began his presentationat the AAD annual meeting yesterday by asking those attending the sessionhow many had heard of Syndrome X. Based on the number of hands raised, hesaid that more dermatologists seem to be aware of this condition, also calledMetabolic Syndrome, which affects 90 million Americans and finds its rootsin high glycerin and insulin levels.
Related Videos
Related Content
